Key Publications using CaRi-Heart® Technology

Lancet, May 2024
Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study | Chan et al.
Perivascular adipose tissue (PVAT) as a source of imaging biomarkers and a therapeutic target. FAI, fat attenuation index.
European Heart Journal, August 2023
Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers: A clinical consensus statement from the European Society of Cardiology Working Group on Coronary Pathophysiology and Micro-circulation | Antoniades et al.
Cardiovascular Research, August 2021
Standardised Measurement of Coronary Inflammation using Cardiovascular CT: Integration in Clinical Care as a Prognostic Medical Device | Oikonomou et al.
The Lancet 2018
Non-invasive Detection of Coronary Inflammation using Computed Tomography and Prediction of Residual Cardiovascular Risk (the CRISP CT study): a Post-Hoc Analysis of Prospective Outcome Data | Oikonomou et al.
Science Translational Medicine 2017
Detecting Human Coronary Inflammation by Imaging Perivascular Fat | Antonopoulos AS, Antoniades C. et al
JACC: Cardiovascular Imaging 2022
Biomarkers of Vascular Inflammation for Cardiovascular Risk Prognostication: A Meta-Analysis | Antonopoulos et. al
JACC 2020
Perivascular Fat Attenuation Index Stratifies Cardiac Risk Associated With High-Risk Plaques in the CRISP-CT Study | Oikonomou et al.
Cardiovascular Research 2024
Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, double-blind placebo-controlled trial | Farina et al.

View All Publications

Get in touch for more information.